Foot Reflexology on Postpartum Sleep Qualıty

March 20, 2019 updated by: Ilkay Arslan, Akdeniz University

Randomized Controlled Trial Of The Effect Of Foot Reflexology On Sleep Quality Of Postpartum Women

Aim and objectives: To determine the efficacy of foot reflexology versus standard care for improvement of the sleep quality of postpartum women following vaginal birth.

Background: Sleeplessness is one of the major problems experienced by women in the postpartum period following vaginal birth.

Design: A single-blind, randomized controlled trial was conducted between July 2016 and March 2017.

Methods: In this trial, a total of 54 postpartum women were divided into the intervention group (n= 24) and control group (n= 30). In the intervention group, four sessions foot reflexology was applied for 15 minutes in each foot, every other days between postpartum 14th- 20th day. Measures included daily and nighttime sleep durations and Postpartum Sleep Quality Scale (PSQS) scores. This study was used the CONSORT scheme.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

This study was a single-blinded, randomized controlled trial with a prospective pretest-posttest experimental design. This study was conducted between July 2016 and March 2017. Postpartum women were visited at their homes following vaginal birth in the obstetrics clinic of XXX State Hospital in Turkey.

To calculate the sample size, we utilized a 95% confidence interval, 80% power, and a 0.8 effect size. Accordingly, the sample size was determined to be 60 (30 control, 30 intervention) as calculated a priori with a t test using G Power package software. The study was completed with 54 women due to some of the women dropping-out of the study, with 24 women in the intervention group and 30 women in the control group. In this study, the simple randomization method (Statistical Analysis System Institute, Cary, North Carolina, version 8.2) was used to create an equal number of samples in both groups. Thus, participants were single-blinded to treatment allocation. Also the first researcher delivered the intervention and, therefore, could not be blinded to allocation. This study was used the CONSORT scheme.

A total of four reflexology sessions were applied in the afternoons every other day between postpartum days 14 through 20. Pretest data were collected on the 14th day and posttest data were collected on the 20th day. This pilot study revealed that no changes were required in the study method. The five women who participated in the pilot study were excluded from the study data.

The intervention group was comprised of 30 women in the early postpartum period. Pretest data were collected on the 14th day postpartum. Then a total of four reflexology sessions were applied for 15 minutes in each foot, in the afternoons, every other day between postpartum 14th-20th day, as the women were available. And posttest data were collected on the 20th day postpartum at the end of the four-reflexology sessions.

The control group of this study was comprised of 30 women in the early postpartum period who had sleep problem and gave vaginal birth. Pretest data were collected on the 14th day postpartum. On the 20th day postpartum, the posttest data were assessed during home visits. These women only received routine postpartum care from public health nurses but did not access the reflexology.

Data were collected by Personal Information Form and Postpartum Sleep Quality Scale. Data were evaluated using SPSS-17 software (Statistical Package for Social Sciences). Descriptive data were expressed as score means, standard deviations, and min-max values, and normal distribution was measured with kurtosis and skewness. The t test and Mann Whitney U test (z) were used to determine the significance of the differences between pretest and posttest sleep duration and quality in the control and intervention groups according to the hypotheses. Values of p < 0.05 were considered significant. Due to the dropouts in the intervention group, an Intention to Treat (ITT) analysis was performed. Mean method was used with the mean of the sample followed for missing data. The study data were presented along with the results of ITT analysis.

This study was approved by the Mersin University Ethical Committee of Clinical Research (approval number: 4/50, date: 23.02.2016) and by the Ethical Committee of Educational Unit of Mersin Public Hospitals Administration. All of the participants provided written informed voluntary consent. Participants were informed that their participation was voluntary, that they were free to quit the study without providing an excuse, that they could contact the researcher by phone as necessary, and that all of the collected data would be kept completely confidential and secured.

Study Type

Interventional

Enrollment (Actual)

60

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 45 years (ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • expression of sleep problem,
  • being literate,
  • being able to communicate in Turkish,
  • aged between 18-45 years old,
  • being in the early postpartum period which lasts 2-6 weeks postpartum
  • having delivered a single fetus with birth weight between 2500 and 4000 grams in the vertex presentation via a vaginal route,
  • currently full breastfeeding

Exclusion Criteria:

  • having experienced complications in the postpartum period (e.g., acute infections and fever states, history of myocardial infarction, irregular blood pressure, epilepsy, diabetes, osteoporosis, deep vein thrombosis, malignant melanoma, eclampsia, and/or preeclampsia),
  • diabetic foot,
  • open wound, varices, edema, or fungal infection in the foot,
  • having been diagnosed with a psychiatric disorder (e.g., postpartum depression, psychosis, etc.), (
  • undergoing pharmacological treatment for sleeplessness,
  • alcohol intake

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: SUPPORTIVE_CARE
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: SINGLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: foot reflexology group
The intervention group was comprised of 30 women in the early postpartum period. Pretest data were collected on the 14th day postpartum. Then a total of four reflexology sessions were applied for 15 minutes in each foot, in the afternoons, every other day between postpartum 14th-20th day, as the women were available. And posttest data were collected on the 20th day postpartum at the end of the four-reflexology sessions.
Four sessions foot reflexology was applied for 15 minutes in each foot, every other days between postpartum 14th- 20th day
NO_INTERVENTION: standard care group no reflexology
The control group of this study was comprised of 30 women in the early postpartum period who had sleep problem and gave vaginal birth. Pretest data were collected on the 14th day postpartum. On the 20th day postpartum, the posttest data were assessed during home visits. These women only received routine postpartum care from public health nurses but did not access the reflexology

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Postpartum Sleep Quality Scale (PSQS)
Time Frame: The prettest data were collected on the 14th day.
The items of the Postpartum Sleep Quality Scale are scored between 0 and 4 on a 5-point Likert scale (0 never, 4 always). Items 1, 2, and 14 are scored in reverse.To calculate the total score, subscale scores are collected. The minimum score of the The Postpartum Sleep Quality Scale is 0, and the maximum available score is 56. Higher PSQS scores indicate worse sleep quality .
The prettest data were collected on the 14th day.
sleep durations
Time Frame: The prettest data were collected on the 14th day.
Personal Information Form
The prettest data were collected on the 14th day.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Postpartum Sleep Quality Scale (PSQS)
Time Frame: The posttest data were collected on the 20th day.
The items of the Postpartum Sleep Quality Scale are scored between 0 and 4 on a 5-point Likert scale (0 never, 4 always). Items 1, 2, and 14 are scored in reverse.To calculate the total score, subscale scores are collected. The minimum score of the The Postpartum Sleep Quality Scale is 0, and the maximum available score is 56. Higher PSQS scores indicate worse sleep quality .
The posttest data were collected on the 20th day.
sleep durations
Time Frame: The posttest data were collected on the 20th day.
Personal Information Form
The posttest data were collected on the 20th day.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Nida SELVİ, Mersin University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

July 1, 2016

Primary Completion (ACTUAL)

March 1, 2017

Study Completion (ACTUAL)

March 1, 2018

Study Registration Dates

First Submitted

March 10, 2019

First Submitted That Met QC Criteria

March 17, 2019

First Posted (ACTUAL)

March 20, 2019

Study Record Updates

Last Update Posted (ACTUAL)

March 21, 2019

Last Update Submitted That Met QC Criteria

March 20, 2019

Last Verified

March 1, 2019

More Information

Terms related to this study

Other Study ID Numbers

  • 01 (Miami VAHS)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Postpartum Women

Clinical Trials on foot reflexology

3
Subscribe